BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Flexible Stenting Solutions Inc.'s Modified FlexStent(R) Biliary Self Expanding Stent System Receives FDA 510(k) SE Clearance


12/22/2010 6:47:43 AM

EATONTOWN, N.J.--(BUSINESS WIRE)-- Flexible Stenting Solutions, Inc. (“FSS”), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received 510(k) clearance for an improved FlexStent® Biliary Self Expanding Stent Delivery System and an expansion of Biliary stent sizes.

The FlexStent® Biliary Self Expanding Stent System is indicated for the palliative treatment of biliary strictures resulting from malignant neoplasms. Expansion of the FlexStent® Biliary Stent size range provides the physician with additional options in the treatment of these strictures. FSS’s nearly fully connected stent has always allowed for a straight forward, simple and accurate delivery. The delivery system improvement builds on the already easy to use system assuring even lower deployment forces thus enabling the physician to quickly perform each deployment.

“FSS continues to be customer- and ease-of-use focused,” commented Janet Burpee, FSS’s CEO. Ms. Burpee further stated that “The modified FlexStent® Biliary Stent Delivery System has been designed for improved manufacturing and lower stent deployment force. FSS’s goal is to simplify the procedure so the physician can focus on the patient.”

About Flexible Stenting Solutions Inc.

Flexible Stenting Solutions Inc. (FSS) is a leading developer of third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. Its fully connected stent has coupled technology with clinical needs by providing an atraumatic, highly durable and fatigue resistant stent with superior radial stiffness, flexibility and conformability. FSS is an ISO 13485:2003 certified company and has received regulatory approvals on several products.

For further information on Flexible Stenting Solutions, please visit the company website at www.flexiblestent.com.

FlexStent® is a registered trademark of Flexible Stenting Solutions, Inc.

© 2010 Flexible Stenting Solutions, Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES